Probiotic drops aim to boost gut health in C-Section infants
NCT ID NCT07608341
First seen Jun 02, 2026 · Last updated Jun 23, 2026 · Updated 4 times
Summary
This study tests whether daily probiotic drops plus vitamin D3 can improve early gut bacteria in healthy babies born by C-section. 150 infants will receive either probiotic or placebo drops for 8 weeks, with stool samples and questionnaires. Results will be compared to vaginally born babies. The goal is to see if probiotics can help C-section infants develop a healthier gut microbiome.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for C-SECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Helsinki University Hospital
Helsinki, Finland
Contact
-
Tampere University Hospital
Tampere, Finland
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Probiotic drops with vitamin D3
What this could lead to
If it works, this could help C-section babies develop a healthier gut microbiome, potentially reducing future health risks.
What could go wrong
This is an early-stage trial with no phase, so results are uncertain. The study is small (150 infants) and may not apply to all C-section babies.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.